tiprankstipranks
Eton Pharmaceuticals Inc (ETON)
NASDAQ:ETON
US Market
ETON
Eton Pharmaceuticals
RESEARCH TOOLSreports
Want to see ETON full AI Analyst Report?

Eton Pharmaceuticals (ETON) Ratios

550 Followers

Eton Pharmaceuticals Ratios

ETON's free cash flow for Q4 2025 was $0.62. For the 2025 fiscal year, ETON's free cash flow was decreased by $ and operating cash flow was $0.12. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.57 1.57 2.06 1.65 3.10
Quick Ratio
 1.17 1.17 1.29 1.60 3.01
Cash Ratio
 0.67 0.67 0.75 1.32 2.52
Solvency Ratio
 >-0.01 >-0.01 -0.05 >-0.01 -0.61
Operating Cash Flow Ratio
 0.00 0.27 0.05 0.42 0.75
Short-Term Operating Cash Flow Coverage
 0.00 1.20 0.00 1.27 4.67
Net Current Asset Value
$ -5.38M$ -5.38M$ -10.67M$ 10.58M$ 8.05M
Leverage Ratios
Debt-to-Assets Ratio
 0.10 0.34 0.39 0.17 0.26
Debt-to-Equity Ratio
 0.35 1.19 1.22 0.35 0.50
Debt-to-Capital Ratio
 0.26 0.54 0.55 0.26 0.33
Long-Term Debt-to-Capital Ratio
 0.02 0.45 0.55 0.00 0.29
Financial Leverage Ratio
 3.52 3.52 3.12 2.05 1.91
Debt Service Coverage Ratio
 0.28 0.30 -0.73 -0.10 -6.28
Interest Coverage Ratio
 -0.18 0.02 -1.30 0.00 0.00
Debt to Market Cap
 0.01 0.07 0.09 0.05 0.09
Interest Debt Per Share
 0.52 1.33 1.23 0.21 0.26
Net Debt to EBITDA
 -4.36 1.23 -10.33 54.93 1.51
Profitability Margins
Gross Profit Margin
53.46%53.46%60.01%66.56%67.38%
EBIT Margin
-0.27%0.09%-6.66%-3.77%-38.87%
EBITDA Margin
4.79%5.15%-3.72%-0.92%-30.52%
Operating Profit Margin
-1.06%0.09%-6.66%-3.77%-38.87%
Pretax Profit Margin
-5.70%-5.70%-9.76%-2.18%-42.45%
Net Profit Margin
-5.75%-5.75%-9.80%-2.96%-42.45%
Continuous Operations Profit Margin
-5.75%-5.75%-9.80%-2.96%-42.45%
Net Income Per EBT
100.94%100.94%100.39%135.85%100.00%
EBT Per EBIT
540.05%-6330.56%146.63%57.80%109.21%
Return on Assets (ROA)
-4.99%-4.99%-5.02%-2.95%-36.04%
Return on Equity (ROE)
-18.84%-17.59%-15.65%-6.05%-68.98%
Return on Capital Employed (ROCE)
-1.57%0.13%-4.62%-7.69%-44.48%
Return on Invested Capital (ROIC)
-1.35%0.12%-4.62%-5.71%-42.14%
Return on Tangible Assets
-7.51%-7.51%-9.27%-3.47%-44.49%
Earnings Yield
-0.73%-1.01%-1.11%-0.83%-12.72%
Efficiency Ratios
Receivables Turnover
 6.80 6.80 7.28 9.28 11.47
Payables Turnover
 3.39 3.39 3.74 5.73 3.93
Inventory Turnover
 2.41 2.41 1.02 11.61 12.45
Fixed Asset Turnover
 125.71 125.71 186.66 210.95 81.73
Asset Turnover
 0.87 0.87 0.51 1.00 0.85
Working Capital Turnover Ratio
 3.20 3.70 2.46 2.62 1.30
Cash Conversion Cycle
 97.26 97.26 309.05 7.02 -31.84
Days of Sales Outstanding
 53.67 53.67 50.16 39.35 31.81
Days of Inventory Outstanding
 151.25 151.25 356.39 31.43 29.32
Days of Payables Outstanding
 107.67 107.67 97.50 63.75 92.97
Operating Cycle
 204.92 204.92 406.55 70.77 61.13
Cash Flow Ratios
Operating Cash Flow Per Share
 0.00 0.39 0.04 0.27 0.19
Free Cash Flow Per Share
 -0.01 0.38 0.04 0.24 0.08
CapEx Per Share
 0.01 0.01 <0.01 0.03 0.11
Free Cash Flow to Operating Cash Flow
 0.00 0.97 0.97 0.89 0.42
Dividend Paid and CapEx Coverage Ratio
 0.00 31.60 37.27 8.79 1.73
Capital Expenditure Coverage Ratio
 0.00 31.60 37.27 8.79 1.73
Operating Cash Flow Coverage Ratio
 0.00 0.34 0.03 1.26 0.74
Operating Cash Flow to Sales Ratio
 0.00 0.13 0.02 0.22 0.23
Free Cash Flow Yield
-0.05%2.24%0.27%5.38%2.87%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -137.90 -98.89 -90.22 -120.01 -7.86
Price-to-Sales (P/S) Ratio
 8.05 5.69 8.84 3.55 3.34
Price-to-Book (P/B) Ratio
 24.26 17.40 14.12 7.26 5.42
Price-to-Free Cash Flow (P/FCF) Ratio
 -1.93K 44.65 365.77 18.60 34.88
Price-to-Operating Cash Flow Ratio
 0.00 43.24 355.96 16.48 14.71
Price-to-Earnings Growth (PEG) Ratio
 2.34 -7.42 -0.29 1.34 -0.02
Price-to-Fair Value
 24.26 17.40 14.12 7.26 5.42
Enterprise Value Multiple
 163.75 111.78 -248.04 -331.06 -9.42
Enterprise Value
 626.68M 460.09M 359.90M 96.34M 61.13M
EV to EBITDA
 163.75 111.78 -248.04 -331.06 -9.42
EV to Sales
 7.84 5.75 9.23 3.04 2.88
EV to Free Cash Flow
 -1.88K 45.15 381.66 15.95 30.07
EV to Operating Cash Flow
 0.00 43.72 371.42 14.14 12.68
Tangible Book Value Per Share
 -0.18 -0.18 -0.40 0.42 0.33
Shareholders’ Equity Per Share
 0.97 0.97 0.94 0.60 0.52
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 >-0.01 -0.36 0.00
Revenue Per Share
 2.97 2.97 1.51 1.23 0.85
Net Income Per Share
 -0.17 -0.17 -0.15 -0.04 -0.36
Tax Burden
 1.01 1.01 1.00 1.36 1.00
Interest Burden
 21.00 -63.31 1.47 0.58 1.09
Research & Development to Revenue
 0.10 0.10 0.08 0.10 0.19
SG&A to Revenue
 0.45 0.45 0.58 0.60 0.87
Stock-Based Compensation to Revenue
 0.07 0.07 0.08 0.10 0.20
Income Quality
 0.00 -2.29 -0.25 -7.28 -0.53
Currency in USD